Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer
Condition(s):Non Castrate Metastatic Prostate CancerLast Updated:November 17, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):Non Castrate Metastatic Prostate CancerLast Updated:November 17, 2017Terminated
Condition(s):Metastatic Triple Negative Breast CancerLast Updated:January 28, 2021Terminated
Condition(s):Breast CancerLast Updated:November 27, 2019Completed
Condition(s):Breast CancerLast Updated:January 23, 2018Terminated
Condition(s):Breast NeoplasmsLast Updated:February 3, 2015Unknown status
Condition(s):Detectable Prostate NodulesLast Updated:March 22, 2017Withdrawn
Condition(s):COVID-19Last Updated:January 27, 2021Recruiting
Condition(s):Covid19; SARS-CoV Infection; Coronavirus InfectionLast Updated:February 11, 2021Recruiting
Condition(s):Breast CancerLast Updated:December 22, 2017Unknown status
Condition(s):HealthyLast Updated:March 2, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.